Neural and Cognitive Correlates of Pragmatic Abilities (APACS_Neuro)

February 29, 2024 updated by: IRCCS San Camillo, Venezia, Italy

Neural and Cognitive Correlates of Pragmatic Communication Abilities

Pragmatics of language refers to the set of abilities that allow one to use and interpret language according to context and, in general, to communicate effectively. Disorders in the pragmatics of language are prevalent in various clinical populations. They are a cause of social withdrawal and worse quality of life, both for patients directly affected and for their family members. Despite this, this type of disorder is rarely considered in neuropsychological assessment and rehabilitation.

This study's objective is to characterize pragmatic deficits in various neurological populations, allowing for the most accurate diagnosis possible and leading to the planning of personalized and effective Rehabilitation Plans.

Study Overview

Detailed Description

To delineate the pragmatic deficit profile for each pathology group, eligible participants will undergo a neuropsychological assessment, subdivided into as many sessions as per the participant's availability and tolerance.

Assessment tools will include:

  • APACS (A test for the Assessment of Pragmatic Abilities and Cognitive Substrates; Arcara and Bambini, 2016)
  • SET (Story-based Empathy Task, Dodich et al., 2015)
  • COAST (Communication Outcome After Stroke, Bambini et al., 2016)
  • PWB (Psychological Well-Being scales, Sirigatti et al., 2009)
  • other neuropsychological assessment tools depending on the participant's pathology and routinely used in the clinical practice within the Institution.

Resulting test scores will be statistically analyze to provide pragmatic and cognitive profiles for each pathology.

Study Type

Observational

Enrollment (Estimated)

324

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Venice
      • Venice-Lido, Venice, Italy, 30126
        • San Camillo IRCCS s.r.l.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Neurological patients and healthy individuals

Description

Inclusion Criteria:

  • Presence of objective neuropsychological assessment using standardized tests used in clinical routine.
  • Ability to knowingly provide written informed consent and , therefore preserved comprehension skills and good understanding of simple verbal requests (for the experimental phase).
  • Being a native speaker of Italian.

Exclusion Criteria:

  • Presence of disability that impairs participation in research.
  • Insufficient knowledge of the Italian language.
  • Refusal to participate in the research.
  • Other relevant prior neurological or psychiatric conditions (other than those determining membership in the experimental group).
  • Comorbidity of multiple conditions that would determine membership in more than one experimental group.
  • Comorbidity with other neurological conditions.
  • Presence of prior psychiatric conditions.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Right Hemispheric Stroke

Specific inclusion criteria for this participants' group are:

- unilateral right hemispheric lesion after an ischemic or hemorrhagic stroke.

There are no specific exclusion criteria for this participants' group (see general exclusion criteria).

Participants will undergo a detailed neuropsychological assessment as detailed in the study's detailed description and outcome measures sections.

  • APACS assessing various aspects of pragmatic communication abilities;
  • SET assessing cognitive and emotional theory of mind;
  • COAST assessing functional communication impairments in daily activities and their impact on the quality of life after the illness onset;
  • PWB assessing the individual's perceived quality of life and psychological well-being;
  • other neuropsychological assessment tools depending on the participant's pathology and routinely used in the clinical practice within the Institution.
Left Hemispheric Stroke

Specific inclusion criteria for this participants' group are:

- unilateral left hemispheric lesion after an ischemic or hemorrhagic stroke.

There are no specific exclusion criteria for this participants' group (see general exclusion criteria).

Participants will undergo a detailed neuropsychological assessment as detailed in the study's detailed description and outcome measures sections.

  • APACS assessing various aspects of pragmatic communication abilities;
  • SET assessing cognitive and emotional theory of mind;
  • COAST assessing functional communication impairments in daily activities and their impact on the quality of life after the illness onset;
  • PWB assessing the individual's perceived quality of life and psychological well-being;
  • other neuropsychological assessment tools depending on the participant's pathology and routinely used in the clinical practice within the Institution.
Traumatic Brain Injury

Specific inclusion criteria for this participants' group are:

  • presence of a traumatic brain injury episode
  • absence of previous neurological and psychiatric conditions.

There are no specific exclusion criteria for this participants' group (see general exclusion criteria).

Participants will undergo a detailed neuropsychological assessment as detailed in the study's detailed description and outcome measures sections.

  • APACS assessing various aspects of pragmatic communication abilities;
  • SET assessing cognitive and emotional theory of mind;
  • COAST assessing functional communication impairments in daily activities and their impact on the quality of life after the illness onset;
  • PWB assessing the individual's perceived quality of life and psychological well-being;
  • other neuropsychological assessment tools depending on the participant's pathology and routinely used in the clinical practice within the Institution.
Right Hemispheric Brain Tumor

Specific inclusion criteria for this participants' group are:

- unilateral right hemispheric brain tumor.

There are no specific exclusion criteria for this participants' group (see general exclusion criteria).

Participants will undergo a detailed neuropsychological assessment as detailed in the study's detailed description and outcome measures sections.

  • APACS assessing various aspects of pragmatic communication abilities;
  • SET assessing cognitive and emotional theory of mind;
  • COAST assessing functional communication impairments in daily activities and their impact on the quality of life after the illness onset;
  • PWB assessing the individual's perceived quality of life and psychological well-being;
  • other neuropsychological assessment tools depending on the participant's pathology and routinely used in the clinical practice within the Institution.
Left Hemispheric Brain Tumor

Specific inclusion criteria for this participants' group are:

- unilateral left hemispheric brain tumor.

There are no specific exclusion criteria for this participants' group (see general exclusion criteria).

Participants will undergo a detailed neuropsychological assessment as detailed in the study's detailed description and outcome measures sections.

  • APACS assessing various aspects of pragmatic communication abilities;
  • SET assessing cognitive and emotional theory of mind;
  • COAST assessing functional communication impairments in daily activities and their impact on the quality of life after the illness onset;
  • PWB assessing the individual's perceived quality of life and psychological well-being;
  • other neuropsychological assessment tools depending on the participant's pathology and routinely used in the clinical practice within the Institution.
Mild Cognitive Impairment

Specific inclusion criteria for this participants' group are:

  • MCI diagnosis according to Petersen et al., 2006 criteria
  • absence of previous neurological and psychiatric conditions.

There are no specific exclusion criteria for this participants' group (see general exclusion criteria).

Participants will undergo a detailed neuropsychological assessment as detailed in the study's detailed description and outcome measures sections.

  • APACS assessing various aspects of pragmatic communication abilities;
  • SET assessing cognitive and emotional theory of mind;
  • COAST assessing functional communication impairments in daily activities and their impact on the quality of life after the illness onset;
  • PWB assessing the individual's perceived quality of life and psychological well-being;
  • other neuropsychological assessment tools depending on the participant's pathology and routinely used in the clinical practice within the Institution.
Healthy Individuals

Specific inclusion criteria for this participants' group are:

- absence of neurological and psychiatric conditions.

There are no specific exclusion criteria for this participants' group (see general exclusion criteria).

Participants will undergo a detailed neuropsychological assessment as detailed in the study's detailed description and outcome measures sections.

  • APACS assessing various aspects of pragmatic communication abilities;
  • SET assessing cognitive and emotional theory of mind;
  • COAST assessing functional communication impairments in daily activities and their impact on the quality of life after the illness onset;
  • PWB assessing the individual's perceived quality of life and psychological well-being;
  • other neuropsychological assessment tools depending on the participant's pathology and routinely used in the clinical practice within the Institution.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pragmatic Profile
Time Frame: after enrollmnet (T0)
results at ASsessemnt of Pragmatics Abilities and Cognitive Substrates (APACS) test
after enrollmnet (T0)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Theory of Mind
Time Frame: after enrollmnet (T0)
Results at Story Empathy Test (SET) score
after enrollmnet (T0)
Functional Communication Abilities
Time Frame: after enrollmnet (T0)
Results at Communication Outcome After Stroke (COAST)
after enrollmnet (T0)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Giorgio Arcara, San Camillo IRCCS Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 29, 2018

Primary Completion (Estimated)

December 31, 2025

Study Completion (Estimated)

December 31, 2025

Study Registration Dates

First Submitted

February 5, 2024

First Submitted That Met QC Criteria

February 29, 2024

First Posted (Actual)

March 6, 2024

Study Record Updates

Last Update Posted (Actual)

March 6, 2024

Last Update Submitted That Met QC Criteria

February 29, 2024

Last Verified

February 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy

Clinical Trials on Neuropsychological assessment

Subscribe